We use cookies for a better user experience. Read our Privacy Policy

I Agree

Serum-free Media Market Insights, 2021-2031

Serum-free Media Market (Media Type: CHO Cell Media, Protein Expression Media, Immunology Media, Insect Cell Media, Hybridoma Media, Stem Cell Media, and Chemically-defined Media; and End-user: Biopharma Industry, Clinical Research Organizations, Research Centers, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Protein-free Medium Gauges Demand to Overcome Challenges in COVID-19 Vaccine Production

With many around the world affected by the COVID-19, pharmaceutical companies are boosting their production capabilities to develop vaccines. Such trends are creating revenue opportunities for players in the serum-free media market. Lonza Group - a Swiss multinational chemicals and biotechnology company, is gaining recognition for its ProVeroTM1 Serum-free Medium, which is of non-animal origin and supports vaccine production.

Companies in the serum-free media market are taking cues from such innovations and increasing the availability of protein-free medium, which is optimized for fast cell proliferation. They are developing several serum-free media (SFM) options that help to reduce production variables for vaccine production. In order to avoid any challenges during the downstream processing of recombinant protein or vaccine production, manufacturers are opting for protein-free medium.

serum free media market infographic

Request a sample to get extensive insights into the Serum-free Media Market

Low Levels of Human Recombinant Insulin in Media Facilitates Downstream Processing

The global serum-free media market is projected to reach US$ 660.4 Mn by 2031. Manufacturers are increasing their output capacities in customized cell culture media. Thermo Fisher Scientific - the U.S. provisioner of scientific instrumentation, reagents & consumables, and software services, is publicizing its Gibco serum-free media, which promotes superior cell growth and viability.

Manufacturers in the serum-free media market are developing medium that enable precise evaluations of cellular function and facilitate consistent performance. Enhanced detection of cellular mediators and for better control over physiological responsiveness is preferred in serum-free media. The absence of proteins and only very low levels of human recombinant insulin facilitate both downstream processing and regulatory compliance.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Key Components of SFM Optimized to Develop Recombinant Therapeutic Proteins

The increasing demand for recombinant protein products is fueling the production of serum-free media. The serum-free media market is expected to advance at a favorable CAGR of 7% during the forecast tenure. Different media contain different formulations that have the potential to adapt to the growth of different cell lines and the production of recombinant protein.

Based on the characteristics of Chinese hamster ovary (CHO) cells and its advantages in recombinant therapeutic protein (RTP) production, key components of SFM are being optimized to different degrees and proportions. The Plackett Burman method (PBM) and the response surface method are routinely used for SFM optimization and can be combined with other statistical methods such as non-parametric Gaussian kernel regression.

FBS-free Medium Eliminates Possibility of Lot Variations in MSCs During Manufacture

Mesenchymal Stem/Stromal Cells (MSCs) hold promising potentials for treating a variety of conditions in veterinary medicine. MSCs are isolated and expanded invitro in a medium that is supplemented with fetal bovine serum (FBS). However, the use of FBS as a medium component during manufacturing may pose several issues. Since FBS can be a source of unwanted pathogens, companies in the serum-free media market are partnering with researchers to develop FBS-free medium that supports both isolation and expansion of MSCs from canine adipose tissue, while removing unwanted pathogens, immune response, and lot-to-lot variations.

Serum-free Hybridoma Helps Prevent Contamination of Cell Culture Facilities

Companies in the serum-free media market are boosting the production of hybridoma media. Leinco Technologies - a biotechnology company in Fenton, Missouri, is gaining popularity for its AlphaGrow Serum Free Hybridoma that offers better lot-to-lot consistency in applications. Increased antibody production and low cost attributes of serum-free hybridoma are being preferred by researchers and scientists.

The inconveniences of serum include the need to screen lots and is subject to variability in cost & quality. Companies are capitalizing on this opportunity, since the presence of contaminating bovine IgG creates issues for researchers. Such findings are triggering the demand for serum-free hybridoma media, as animal-derived ingredients carry the risk of introducing adventitious agents such as viruses and prions that can contaminate cell culture facilities.

Serum-free Cell Culturing Gaining Prominence in Biological Facilities

Apart from CHO cell media and protein expression media, companies in the serum-free media market are increasing their focus on human microglial cell culture serum-free media. On the other hand, serum-free cell culturing is gaining recognition in biological facilities. Researchers in cell biology are familiar with adding bovine or calf serum to cell cultures. Unfortunately, adding serum means adding a highly variable and non-standardized product to a well ordered system. Hence, manufacturers are leveraging this opportunity to boost product innovations.

Companies are increasing the availability of chemically defined serum-free media. Serum-free cell culturing is gaining market prominence, since objections have been raised to the use of serum in cell culture on regulatory and ethical grounds.

serum free media market segmentation

Stuck in a neck-to-neck competition with other brands? Request a custom report on Serum-free Media Market

Analysts’ Viewpoint

Media formulations without FBS are essential for COVID-19 vaccine production and has led to the popularity of protein-free medium. Since FBS is associated with inconsistencies between batches of MSCs, companies in the serum-free media market should develop FBS-free medium that supports both isolation and expansion of MSCs from canine adipose tissue, while removing unwanted pathogens, immune response, and lot-to-lot variations.

Serum-free hybridoma media ensures consistent downstream purification results. This medium eliminates ethical concerns surrounding the collection of FBS. MSCs cultivated in FBS-free media exhibits a more uniform size and shorter population doubling time as compared to the FBS medium. Manufacturers are boosting credibility credentials by minimizing waste in labs by adopting bottles that utilize less source material than comparable media bottles on the market.

Serum-free Media Market: Overview

  • According to Transparency Market Research’s latest research report on the global serum-free media market for the historical period 2017–2019 and the forecast period 2021–2031, easier downstream processing of products after production from media and increase in demand for various recombinant proteins & types of culture are projected to drive the global serum-free media market during the forecast period
  • According to the report, the global serum-free media market was valued at US$ 320 Mn in 2020 and is anticipated to expand at a CAGR of 7% from 2021 to 2031

Easier Downstream Processing of Products Post Production from Media

  • Concentration of proteins in serum media is generally higher than proteins produced by mammalian cells in vivo, which makes separation of target molecule difficult
  • Serum proteins in cell culture media are significant contaminants and could interact with the component of interest, resulting in slow purification of the molecule
  • The inVitro protein concentration is low in serum-free media, resulting in low levels of contaminants. Hence, the target protein (lead molecule) is easier to purify with higher recovery through various methods such as centrifugation, HPLC, and mass spectrometry.
  • Once the protein is produced in the serum-free media, it is tested for accuracy through various methods such as SDS PAGE, and mass spectrometry, which gives an idea whether the isolated protein is of interest
  • Therefore, easier downstream processing of products post production from media is a major driver for the global serum-free media market

Increase in Demand for Various Recombinant Proteins and Types of Culture

  • Presently, demand for pain relief devices is high due to arthritic pain, joint pain, knee pain, etc. Additionally, increase in incidence and prevalence of arthritis & joint diseases drive the demand of pain relief devices.
  • According to CDC, one in every 30 adults in the U.S. suffers from pain problems, which is considered the eighth leading risk factor for disability and premature deaths. Medication and lifestyle changes are effective and affordable; however, the overall rate of pain relief control is suboptimal.
  • Serum-free media is used in various types of suspension & adherent cultures for the production of immunological cells such as IL-2, IL-4, cytotoxic lymphocytes (CTLs), and monocytes, which are used in production of various vaccines
  • Hence, increase in demand for recombinant proteins in various chronic diseases such as cancer is likely to propel the global serum-free media market

Continuous Research & Development for Development of Novel Therapeutic Drugs

  • Need of development of novel therapeutic drugs has increased due to various disadvantages associated with conventional and regular drugs due to their associated side effects and ineffectiveness in providing the required relief from the particular body indication
  • Various research organizations and healthcare companies are involved in finding a better and modified version of existing drugs that not only can provide relief to various disease indications, but can also treat major diseases such as cancer
  • Healthcare pharmaceutical & drug manufacturing companies are making significant investment in the research & development of novel therapeutic drugs, owing to increase in patient care and preference for these drugs
  • Serum-free media is gaining popularity among major industry players. Hence, the serum-free media market is anticipated to expand at a high CAGR during the forecast period.

Serum-free Media Market: Competition Landscape

  • This report profiles major players operating in the global serum-free media market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global serum-free media market is moderately fragmented with the presence of a large number of leading players and several small players in regional markets. Top players account for major share of the global serum-free media market.
  • Prominent players operating in the global serum-free media market include
    • Thermo Fisher Scientific
    • Athena Environmental Sciences
    • Pan Biotech
    • Bichrom
    • Irvine Scientific
    • Biological Industries
    • Sigma-Aldrich
    • CellGenix
    • HiMedia Laboratories
  • The report on the global serum-free media market discusses individual strategies, followed by company profiles. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global serum-free media market.

Serum-free Media Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 320 Mn

Market Forecast Value in 2031

US$ 660.4 Mn

Growth Rate (CAGR)

7%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value & ‘000 Units for Volume

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and key product/brand analysis.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, key financials, etc.

Format

Electronic (PDF) + Excel

Market Segmentation

  • Media Type
    • CHO Cell Media
    • Protein Expression Media
    • Immunology Media
    • Insect Cell Media
    • Hybridoma Media
    • Stem Cell Media
    • Chemically-defined Media
  • End-user
    • Biopharma Industry
    • Clinical Research Organizations
    • Research Centers
    • Others

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • South America

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Russia
  • Japan
  • China
  • India
  • South Korea
  • ASEAN
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Thermo Fisher Scientific
  • Athena Environmental Sciences
  • Pan Biotech
  • Bichrom
  • Irvine Scientific
  • Biological Industries
  • Sigma-Aldrich
  • CellGenix
  • HiMedia Laboratories

Customization Scope

Available upon request

Pricing

Available upon request

Serum-free Media Market – Segmentation

Media Type
  • CHO Cell Media
  • Protein Expression Media
  • Immunology Media
  • Insect Cell Media
  • Hybridoma Media
  • Stem Cell Media
  • Chemically Defined Media
End-user
  • Biopharma Industry
  • Clinical Research Organizations
  • Research Centers
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Serum-free Media Market Insights, 2021-2031

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of serum-free media market?

Serum-free media market is projected to reach US$ 660.4 Mn by 2031

What is the anticipated CAGR of the serum-free media market in the forecast period?

Serum-free media market is expected to advance at a favorable CAGR of 7% during 2021-2031

What are the key driving factors for the growth of the serum-free media market?

Serum-free media market is driven by increase in demand for various recombinant proteins & types of culture

Which region is expected to project the highest market share in the global serum-free media market?

North America accounted for a major share of the global serum-free media market

Who are the key players in the global serum-free media market?

Key players operating in the global serum-free media market include Thermo Fisher Scientific, Athena Environmental Sciences, Pan Biotech, Bichrom, Irvine Scientific

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Serum-free Media Market

4. Market Overview

    4.1. Introduction

        4.1.1. Media type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Serum-free Media Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

5. Key Insights

    5.1. Key Product/brand Analysis

    5.2. Applications of different Serum-free Media’s in Cell culture

    5.3. COVID-19 Pandemic Impact on Serum-free Media Market

6. Global Serum-free Media Market Analysis and Forecast, by Media Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Media Type, 2017-2031

        6.3.1. CHO Cell Media

        6.3.2. Protein Expression Media

        6.3.3. Immunology Media

        6.3.4. Insect Cell Media

        6.3.5. Hybridoma Media

        6.3.6. Stem Cell Media

        6.3.7. Chemically-defined Media

    6.4. Market Attractiveness Analysis, by Media Type

7. Global Serum-free Media Market Analysis and Forecasts, By End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by End-user, 2017–2031

        7.3.1. Biopharma Industry

        7.3.2. Clinical Research Organizations

        7.3.3. Research Centers

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by End-user

8. Global Serum-free Media Market Analysis and Forecasts, By Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Serum-free Media Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value Forecast, by Media Type, 2017–2031

        9.2.1. CHO Cell Media

        9.2.2. Protein Expression Media

        9.2.3. Immunology Media

        9.2.4. Insect Cell Media

        9.2.5. Hybridoma Media

        9.2.6. Stem Cell Media

        9.2.7. Chemically-defined Media

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Biopharma Industry

        9.3.2. Clinical Research Organizations

        9.3.3. Research Centers

        9.3.4. Others

    9.4. Market Value Forecast, by Country, 2017–2031

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Media Type

        9.5.2. By End-user

        9.5.3. By Country

10. Europe Serum-free Media Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Media Type, 2017–2031

        10.2.1. CHO Cell Media

        10.2.2. Protein Expression Media

        10.2.3. Immunology Media

        10.2.4. Insect Cell Media

        10.2.5. Hybridoma Media

        10.2.6. Stem Cell Media

        10.2.7. Chemically-defined Media

    10.3. Market Value Forecast, by End-user, 2017–2031

        10.3.1. Biopharma Industry

        10.3.2. Clinical Research Organizations

        10.3.3. Research Centers

        10.3.4. Others

    10.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Media Type

        10.5.2. By End-user

        10.5.3. By Country/Sub-region

11. Asia Pacific Serum-free Media Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Media Type, 2017–2031

        11.2.1. CHO Cell Media

        11.2.2. Protein Expression Media

        11.2.3. Immunology Media

        11.2.4. Insect Cell Media

        11.2.5. Hybridoma Media

        11.2.6. Stem Cell Media

        11.2.7. Chemically-defined Media

    11.3. Market Value Forecast, by End-user, 2017–2031

        11.3.1. Biopharma Industry

        11.3.2. Clinical Research Organizations

        11.3.3. Research Centers

        11.3.4. Others

    11.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Media Type

        11.5.2. By End-user

        11.5.3. By Country/Sub-region

12. Latin America Serum-free Media Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Media Type, 2017–2031

        12.2.1. CHO Cell Media

        12.2.2. Protein Expression Media

        12.2.3. Immunology Media

        12.2.4. Insect Cell Media

        12.2.5. Hybridoma Media

        12.2.6. Stem Cell Media

        12.2.7. Chemically-defined Media

    12.3. Market Value Forecast, by End-user, 2017–2031

        12.3.1. Biopharma Industry

        12.3.2. Clinical Research Organizations

        12.3.3. Research Centers

        12.3.4. Others

    12.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Media Type

        12.5.2. By End-user

        12.5.3. By Country/Sub-region

13. Middle East & Africa Serum-free Media Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Media Type, 2017–2031

        13.2.1. CHO Cell Media

        13.2.2. Protein Expression Media

        13.2.3. Immunology Media

        13.2.4. Insect Cell Media

        13.2.5. Hybridoma Media

        13.2.6. Stem Cell Media

        13.2.7. Chemically-defined Media

    13.3. Market Value Forecast, by End-user, 2017–2031

        13.3.1. Biopharma Industry

        13.3.2. Clinical Research Organizations

        13.3.3. Research Centers

        13.3.4. Others

    13.4. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Media Type

        13.5.2. By End-user

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis by Company (2020)

    14.3. Company Profiles

        14.3.1. Thermo Fisher Scientific

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Strategic Overview

        14.3.2. Athena Environmental Sciences

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Strategic Overview

        14.3.3. Pan Biotech

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Strategic Overview

        14.3.4. Sigma-Aldrich

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Strategic Overview

        14.3.5. CellGenix

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Strategic Overview

        14.3.6. HiMedia Laboratories

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Strategic Overview

        14.3.7. Biological Industries

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Strategic Overview

        14.3.8. Irvine Scientific

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Strategic Overview

List of Tables

Table 01: Global Serum-free Media Market Value (US$ Mn) Forecast, by Media Type, 2017–2031

Table 02: Global Serum-free Media Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 03: Global Serum-free Media Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 04: North America Serum-free Media Market Value (US$ Mn) Forecast, by Countries, 2017–2031

Table 05: North America Serum-free Media Market Value (US$ Mn) Forecast, by Media Type, 2017–2031

Table 06: North America Serum-free Media Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Europe Serum-free Media Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2017-2031

Table 08: Europe Serum-free Media Market Value (US$ Mn) Forecast, by Media Type, 2017-2031

Table 09: Europe Serum-free Media Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 10: Asia Pacific Serum-free Media Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2017-2031

Table 11: Asia Pacific Serum-free Media Market Value (US$ Mn) Forecast, by Media Type, 2017-2031

Table 12: Asia Pacific Serum-free Media Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 13: Latin America Serum-free Media Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2017-2031

Table 14: Latin America Serum-free Media Market Value (US$ Mn) Forecast, by Media Type, 2017-2031

Table 15: Latin America Serum-free Media Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 16: Middle East & Africa Serum-free Media Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2017-2031

Table 17: Middle East & Africa Serum-free Media Market Value (US$ Mn) Forecast, by Media Type, 2017-2031

Table 18: Middle East & Africa Serum-free Media Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Serum-free Media Market Value (US$ Mn) Forecast, 2017-2031

Figure 02: Global Serum-free Media Market Value Share, by Media Type, 2020

Figure 03: Global Serum-free Media Market Value Share, by End-user, 2020

Figure 04: Global Serum-free Media Market Value Share, by Region, 2020

Figure 05: Global Serum-free Media Market Value Share Analysis, by Media Type, 2020 and 2031

Figure 06: Global Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 07: Global Serum-free Media Market Revenue (US$ Mn), by CHO Cell Media, 2017–2031

Figure 08: Global Serum-free Media Market Revenue (US$ Mn), by Protein Expression Media, 2017–2031

Figure 09: Global Serum-free Media Market Revenue (US$ Mn), by Immunology Media, 2017–2031

Figure 10: Global Serum-free Media Market Revenue (US$ Mn), by Insect Cell Media, 2017–2031

Figure 11: Global Serum-free Media Market Revenue (US$ Mn), by Hybridoma Media, 2017–2031

Figure 12: Global Serum-free Media Market Revenue (US$ Mn), by Stem Cell Media, 2017–2031

Figure 13: Global Serum-free Media Market Revenue (US$ Mn), by chemically defined Media, 2017–2031

Figure 14: Global Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 15: Global Serum-free Media Market Value Share Analysis, by End-user, 2020 and 2031

Figure 16: Global Serum-free Media Market Revenue (US$ Mn), by Biopharma Industry, 2017–2031

Figure 17: Global Serum-free Media Market Revenue (US$ Mn), by Clinical Research Organizations, 2017–2031

Figure 18: Global Serum-free Media Market Revenue (US$ Mn), by Research Centers, 2017–2031

Figure 19: Global Serum-free Media Market Revenue (US$ Mn), by Others, 2017–2031

Figure 20: Global Serum-free Media Market Attractiveness Analysis, by End-user, 2021–2031

Figure 21: Global Serum-free Media Market Value Share Analysis, by Region, 2020 and 2031

Figure 22: Global Serum-free Media Market Analysis, by Region

Figure 23: North America Serum-free Media Market Value (US$ Mn) Forecast 2017–2031

Figure 24: North America Serum-free Media Market Value Share (%), by Country, 2020 and 2031

Figure 25: North America Serum-free Media Market Attractiveness Analysis, by Country, 2021–2031

Figure 26: North America Serum-free Media Market Value Share Analysis, by Media Type, 2020 and 2031

Figure 27: North America Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 28: North America Serum-free Media Market Value Share Analysis, by End-user, 2020 and 2031

Figure 29: North America Serum-free Media Market Attractiveness Analysis, by End-user, 2021–2031

Figure 30: Europe Serum-free Media Market Value (US$ Mn) Forecast 2017–2031

Figure 31: Europe Serum-free Media Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 32: Europe Serum-free Media Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 33: Europe Serum-free Media Market Value Share Analysis, by Media Type, 2020 and 2031

Figure 34: Europe Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 35: Europe Serum-free Media Market Value Share Analysis, by End-user, 2020 and 2031

Figure 36: Europe Serum-free Media Market Attractiveness Analysis, by End-user, 2021–2031

Figure 37: Asia Pacific Serum-free Media Market Value (US$ Mn) Forecast 2017–2031

Figure 38: Asia Pacific Serum-free Media Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 39: Asia Pacific Serum-free Media Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 40: Asia Pacific Serum-free Media Market Value Share Analysis, by Media Type, 2020 and 2031

Figure 41: Asia Pacific Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 42: Asia Pacific Serum-free Media Market Value Share Analysis, by End-user, 2020 and 2031

Figure 43: Asia Pacific Serum-free Media Market Attractiveness Analysis, by End-user, 2021–2031

Figure 44: Latin America Serum-free Media Market Value (US$ Mn) Forecast 2017–2031

Figure 45: Latin America Serum-free Media Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 46: Latin America Serum-free Media Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 47: Latin America Serum-free Media Market Value Share Analysis, by Media Type, 2020 and 2031

Figure 48: Latin America Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 49: Latin America Serum-free Media Market Value Share Analysis, by End-user, 2020 and 2031

Figure 50: Latin America Serum-free Media Market Attractiveness Analysis, by End-user, 2021–2031

Figure 51: Middle East & Africa Serum-free Media Market Value (US$ Mn) Forecast 2017–2031

Figure 52: Middle East & Africa Serum-free Media Market Value Share (%), by Country/Sub-region, 2020 and 2031

Figure 53: Middle East & Africa Serum-free Media Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 54: Middle East & Africa Serum-free Media Market Value Share Analysis, by Media Type, 2020 and 2031

Figure 55: Middle East & Africa Serum-free Media Market Attractiveness Analysis, by Media Type, 2021–2031

Figure 56: Middle East & Africa Serum-free Media Market Value Share Analysis, by End-user, 2020 and 2031

Figure 57: Middle East & Africa Serum-free Media Market Attractiveness Analysis, by End-user, 2021–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

983

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved